1. Home
  2. AEVA vs AVTX Comparison

AEVA vs AVTX Comparison

Compare AEVA & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeva Technologies Inc.

AEVA

Aeva Technologies Inc.

HOLD

Current Price

$15.53

Market Cap

1.1B

ML Signal

HOLD

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

HOLD

Current Price

$19.24

Market Cap

982.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEVA
AVTX
Founded
2019
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
982.5M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
AEVA
AVTX
Price
$15.53
$19.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$26.50
$40.57
AVG Volume (30 Days)
1.9M
690.5K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
10.53
72.07
EPS
N/A
N/A
Revenue
N/A
$27,813,137.00
Revenue This Year
$85.37
N/A
Revenue Next Year
$132.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2312.27
52 Week Low
$8.83
$9.54
52 Week High
$31.30
$24.27

Technical Indicators

Market Signals
Indicator
AEVA
AVTX
Relative Strength Index (RSI) 37.91 46.41
Support Level $13.80 $17.40
Resistance Level $17.38 $18.95
Average True Range (ATR) 1.23 0.83
MACD -0.50 -0.16
Stochastic Oscillator 6.38 4.80

Price Performance

Historical Comparison
AEVA
AVTX

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The 4D LiDAR sensors are designed to detect both velocity and position, supporting perception and decision-making in automated systems. The company operates in North America, EMEA, and Asia. The company's revenue consists of sales of perception solutions or sensing systems and non-recurring engineering services. Geographically, it derives the majority of its revenue from North America.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: